AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.
AstraZeneca has axed plans to build a £450million vaccine manufacturing plant because of a lack of Government support in the ...
AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp ...
In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in ...
AstraZeneca has axed plans to invest £450 million in a vaccine manufacturing plant in Merseyside in a fresh blow to Labour’s ...
The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...
AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government’s proposal' ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...